ModelEdge

Amgen Inc
AMGN
Filing Type10-K
Filing Date2/13/2024
Updated2/14/24, 9:23 AM

Filing

10-K
Earnings Release

Exhibits

10-KFY 2023
EX-4.33DESCRIPTION OF SECURITIES
EX-10.2FORM OF GRANT OF STOCK OPTION AGREEMENT
EX-10.3FORM OF RESTRICTED STOCK UNIT AGREEMENT
EX-10.5FORM OF PERFORMANCE UNIT AGREEMENT
EX-10.6AMGEN INC. 2009 DIRECTOR EQUITY INCENTIVE PROGRAM
EX-10.9 5FIFTH AMENDMENT TO SUPPLEMENTAL RETIREMENT PLAN
EX-10.12 4FOURTH AMENDMENT TO NONQUALIFIED DEFERRED COMPENSATION PLAN
EX-10.14AGREEMENT BETWEEN AMGEN INC. AND JAMES BRADNER
EX-10.17COLLABORATION AND LICENSE AGREEMENT BETWEEN AMGEN INC. AND CELLTECH R&D LIMITED
EX-10.17 1AMENDMENT NO 2 TO CELLTECH COLLABORATION AND LICENSE AGREEMENT
EX-10.22 5LETTER AGREEMENT RE FTE RATES
EX-21SUBSIDIARIES OF THE COMPANY
EX-31RULE 13A-14(A) CERTIFICATIONS
EX-32SECTION 1350 CERTIFICATIONS
EX-97POLICY ON RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic